Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

NCT03748524 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Immunity, Cellular

Interventions

DRUG: Influenza Vaccine

Sponsor

Washington University School of Medicine